UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GC Pharma to supply Covid-19 treatment for free
GC Pharma said that it would provide GC5131A, the world's first plasma ...
by Lee Han-soo
|
2020-05-18 11:36
라인
Medytox’s earnings plummet amid lawsuit against Daewoong
Medytox, the nation’s largest botulinum toxin maker by market share, suffer...
by Jeong Sae-im
|
2020-05-18 11:33
라인
‘Many shareholders suffered from Medytox’s public notice of false information’
OhKims Law and Company is recruiting investors for its second suit against ...
by Shim Hyun-tai
|
2020-05-15 17:40
라인
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
Hanmi Pharmaceutical’s diabetes drug candidate efpeglenatide, which had led...
by Jeong Sae-im
|
2020-05-15 13:14
라인
‘Lynparza extended survival of ovarian cancer patients’
AstraZeneca said Lynparza (ingredient: olaparib) has become the first poly ...
by Kim Yun-mi
|
2020-05-14 15:14
라인
Sanofi’s return of rights on efpeglenatide perplexes Hanmi
Hanmi Pharmaceutical said Thursday that Sanofi informed it of intention to ...
by Lee Han-soo
|
2020-05-14 10:48
라인
GC Wellbeing’s placenta injection shows efficacy on Covid-19
GC Wellbeing, in collaboration with the research team of the Chungbuk Natio...
by Lee Han-soo
|
2020-05-13 16:02
라인
Huons Global to confirm BTX efficacy in treating square jaws
Huons Global said that the Ministry of Food and Drug Safety has given it th...
by Lee Han-soo
|
2020-05-13 15:45
라인
AZ, Takeda use different strategies on ovarian cancer
AstraZeneca’s Lynparza (ingredient: olaparib) and Takeda’s Zejula (nirapari...
by Kim Yun-mi
|
2020-05-13 12:34
라인
Enzychem Lifesciences to start P2 trial of Covid-19 treatment
Enzychem Lifesciences said that the Ministry of Food and Drug Safety has ap...
by Lee Han-soo
|
2020-05-13 11:14
라인
YD Life Science proves efficacy of diabetic treatment
YD Life Science said that it has confirmed the efficacy of YD-312, a diabet...
by Lee Han-soo
|
2020-05-13 11:14
라인
Hugel names new CEO of its US offshoot
Hugel said Monday that it has appointed James P. Hartman as the new CEO of ...
by Lee Han-soo
|
2020-05-12 17:32
라인
SK Biopharmaceuticals launches epilepsy drug in US
SK Biopharmaceuticals said that it has launched Xcopri, a treatment for par...
by Lee Han-soo
|
2020-05-12 16:30
라인
Sillajen CEO arrested for profiteering with undisclosed information
The Seoul Southern District Court on Tuesday issued an arrest warrant for S...
by Lee Han-soo
|
2020-05-12 15:35
라인
Daewon to export propofol products to Luxembourg
Daewon Pharmaceutical said Monday that it would make a contingency shipment...
by Shim Hyun-tai
|
2020-05-12 15:25
라인
MSD Korea, Mundipharma Korea in mandatory work-from-home mode, again
MSD Korea and Mundipharma Korea ordered their employees to work from home a...
by Kim Yun-mi
|
2020-05-12 11:57
라인
AbbVie finishes takeover of Allergan
AbbVie announced that it has completed the acquisition of Allergan followin...
by Lee Han-soo
|
2020-05-11 17:15
라인
Boryung gets local sales rights for Eli Lilly’s cancer drug
Boryung Pharmaceutical said it has obtained the right to market Eli Lilly’s...
by Lee Han-soo
|
2020-05-11 17:15
라인
ST Pharm's P1 trial of AIDS treatment gets French regulator’s nod
ST Pharm said that France's drug regulatory agency, ANSM, has approved ...
by Lee Han-soo
|
2020-05-11 14:38
라인
Shinpoong, Bukwang stocks jump on Covid-19 drug candidates
Shares of two Korean pharmaceutical companies have shot up since the first ...
by Jeong Sae-im
|
2020-05-11 12:03
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top